E1	Condition:T1 Name:T2
E3	Condition:T3 Name:T4
E5	Condition:T5 Name:T6
E7	Condition:T7 Name:T8
E11	Condition:T11 Name:T12 Severity:T107
E13	Condition:T13 Name:T14
E15	Observation:T15 Name:T16 Eq-Comparison:E6
E17	Condition:T17 Name:T18
E19	Condition:T19 Name:T20
E21	Condition:T21 Name:T22
E23	Condition:T23 Name:T24
E25	Condition:T25 Name:T26
E27	Condition:T27 Name:T28
E29	Condition:T29 Name:T30
E32	Condition:T32 Name:T33
E34	Condition:T34 Name:T35
E36	Condition:T36 Name:T37 Stage:E14
E38	Condition:T38 Name:T39
E39	Age:T44 Eq-Comparison:E4
E40	Eq-Comparison:T50 Operator:T40 Value:T47 Unit:T65
E2	Or:T52 Arg:T31 Arg2:T51
E4	Eq-Comparison:T53 Temporal-Unit:T41 Operator:T54 Value:T45
E6	Eq-Comparison:T55 Unit:T57 Operator:T56 Value:T46
E8	Observation:T58 Name:T59
E10	Observation:T60 Name:T61 Polarity:T62
E12	Observation:T63 Name:T64 Eq-Comparison:E40
E20	Condition:T69 Name:T70
E22	Assertion:T71 Asserted:E26
E24	Observation:T72 Stability:T118
E26	Negation:T73 Negates:T118
E28	Or:T74 Arg:E7 Arg2:E13
E9	Drug:T9 Name:T10 Temporality:E33
E30	Drug:T75 Name:T76
E31	Drug:T77 Name:T78
E33	Eq-Comparison:T79 Temporal-Unit:T42 Value:T48
E35	Study:T80
E37	Temporal-Connection:T81 Arg2:E35 Arg:E33
E41	Condition:T82
E42	Assertion:T83 Asserted:E43
E43	Condition:T84 Name:T85
E44	Condition:T86 Name:T87
E45	Or:T88 Arg:E44 Arg2:E21
E46	Procedure:T89 Name:T90 Temporality:E47
E47	Eq-Comparison:T91 Temporal-Unit:T43 Value:T49
E48	Study:T92
E49	Temporal-Connection:T93 Arg:E47 Arg2:E48
E50	Condition:T94 Name:T95
E51	Condition:T96 Name:T97
E52	Assertion:T98 Asserted:E51
E53	Condition:T99 Name:T100
E54	Or:T101 Arg:E51 Arg2:E53
E55	Procedure:T102 Name:T103 Temporality:E64
E56	Condition:T104 Name:T105
E57	Or:T106 Arg:E25 Arg2:E56
E58	Modifier:T108 Modifies:T12
E59	Modifier:T109 Modifies:T12
E60	Or:T110 Arg:E58 Arg2:E59
E14	Eq-Comparison:T66 Unit:T67 Value:T68
E16	Eq-Comparison:T111 Unit:T112 Value:T113
E18	Or:T114 Arg:E16 Arg2:E14
E61	Modifier:T115 Modifies:T35
E62	Modifier:T116 Modifies:T2
E63	Modifier:T117 Modifies:T6
E64	Eq-Comparison:T119 Temporal-Period:T120
T1	Condition 338 358	macular degeneration
T2	Condition-Name 338 358	macular degeneration
T3	Condition 801 829	systemic lupus erythematosus
T4	Condition-Name 801 829	systemic lupus erythematosus
T5	Condition 259 267	glaucoma
T6	Condition-Name 259 267	glaucoma
T7	Condition 523 542	Ocular inflammation
T8	Condition-Name 523 542	Ocular inflammation
T11	Condition 1122 1137	organic disease
T12	Condition-Name 1122 1137	organic disease
T13	Condition 547 561	ocular disease
T14	Condition-Name 547 561	ocular disease
T15	Observation 97 106	ametropia
T16	Observation-Name 97 106	ametropia
T17	Condition 835 844	Porphyria
T18	Condition-Name 835 844	Porphyria
T19	Condition 846 854	Vitiligo
T20	Condition-Name 846 854	Vitiligo
T21	Condition 882 890	Albinism
T22	Condition-Name 882 890	Albinism
T23	Condition 920 928	epilepsy
T24	Condition-Name 920 928	epilepsy
T25	Condition 1070 1078	disorder
T26	Condition-Name 1070 1078	disorder
T27	Condition 278 282	POAG
T28	Condition-Name 278 282	POAG
T29	Condition 290 299	diagnosed
T30	Condition-Name 300 304	POAG
T31	Life-Stage-And-Gender 25 28	men
T32	Condition 360 363	AMD
T33	Condition-Name 360 363	AMD
T34	Condition 385 388	AMD
T35	Condition-Name 385 388	AMD
T36	Condition 426 429	AMD
T37	Condition-Name 426 429	AMD
T38	Condition 830 833	SLE
T39	Condition-Name 830 833	SLE
T40	Eq-Operator 313 315	<=
T41	Eq-Temporal-Unit 52 57	years
T42	Eq-Temporal-Unit 683 689	months
T43	Eq-Temporal-Unit 958 964	months
T44	Age 39 43	aged
T45	Eq-Value 49 51	18
T46	Eq-Value 113 114	3
T47	Eq-Value 316 318	10
T48	Eq-Value 681 682	3
T49	Eq-Value 956 957	3
T50	Eq-Comparison 313 318	<= 10
T51	Life-Stage-And-Gender 33 38	women
T52	Or 29 32	and
T53	Eq-Comparison 44 57	over 18 years
T54	Eq-Operator 44 48	over
T55	Eq-Comparison 107 123	below 3 diopters
T56	Eq-Operator 107 112	below
T57	Eq-Unit 115 123	diopters
T58	Observation 180 187	healthy
T59	Observation-Name 180 187	healthy
T60	Observation 212 235	ophthalmologic findings
T61	Observation-Name 212 235	ophthalmologic findings
T62	Polarity 205 211	normal
T63	Observation 310 312	MD
T64	Observation-Name 310 312	MD
T65	Eq-Unit 319 321	dB
T69	Condition 471 484	abnormalities
T70	Condition-Name 471 484	abnormalities
T71	Assertion 485 495	preventing
T72	Observation 505 517	measurements
T73	Negation 485 495	preventing
T74	Or 543 546	and
T9	Drug 606 633	photosensitizing medication
T10	Drug-Name 606 633	photosensitizing medication
T75	Drug 635 651	phototoxic drugs
T76	Drug-Name 635 651	phototoxic drugs
T77	Drug 653 672	photoallergic drugs
T78	Drug-Name 653 672	photoallergic drugs
T79	Eq-Comparison 681 689	3 months
T80	Study 704 709	study
T81	Temporal-Connection 690 699	preceding
T82	Condition 731 740	condition
T83	Assertion 750 764	possibility of
T84	Condition 773 789	photosensitivity
T85	Condition-Name 773 789	photosensitivity
T86	Condition 856 877	Xeroderma Pigmentosum
T87	Condition-Name 856 877	Xeroderma Pigmentosum
T88	Or 878 881	and
T89	Procedure 934 948	Ocular surgery
T90	Procedure-Name 934 948	Ocular surgery
T91	Eq-Comparison 956 964	3 months
T92	Study 979 984	study
T93	Temporal-Connection 965 974	preceding
T94	Condition 990 999	Pregnancy
T95	Condition-Name 990 999	Pregnancy
T96	Condition 1009 1018	pregnancy
T97	Condition-Name 1009 1018	pregnancy
T98	Assertion 1001 1008	planned
T99	Condition 1022 1031	lactating
T100	Condition-Name 1022 1031	lactating
T101	Or 1019 1021	or
T102	Procedure 1052 1060	surgical
T103	Procedure-Name 1052 1060	surgical
T104	Condition 1082 1089	disease
T105	Condition-Name 1082 1089	disease
T106	Or 1079 1081	or
T107	Severity 1115 1121	severe
T108	Modifier 1098 1103	acute
T109	Modifier 1107 1114	chronic
T110	Or 1104 1106	or
T66	Eq-Comparison 416 425	stage III
T67	Eq-Unit 416 421	stage
T68	Eq-Value 422 425	III
T111	Eq-Comparison 404 412	stage II
T112	Eq-Unit 404 409	stage
T113	Eq-Value 410 412	II
T114	Or 413 415	or
T115	Modifier 381 384	dry
T116	Modifier 326 337	age-related
T117	Modifier 240 258	primary open angle
T118	Stability 496 504	reliable
T119	Eq-Comparison 1061 1068	history
T120	Eq-Temporal-Period 1061 1068	history
A1	Eq-Operator-Value T40 LTEQ
A2	Eq-Temporal-Unit-Value T41 year
A3	Eq-Temporal-Unit-Value T42 month
A4	Eq-Temporal-Unit-Value T43 month
A5	Life-Stage-And-Gender-Type T31 male
A6	Life-Stage-And-Gender-Type T51 female
A7	Eq-Operator-Value T54 GT
A8	Eq-Operator-Value T56 LT
A9	Polarity-Value T62 normal
A10	Assertion-Type-Value E22 hypothetical
A11	Temporal-Connection-Type-Value E37 before
A12	Assertion-Type-Value E42 possible
A13	Temporal-Connection-Type-Value E49 before
A14	Assertion-Type-Value E52 intention
A15	Severity-Value T107 severe
A16	Stability-Value T118 stable
A17	Eq-Temporal-Period-Value T120 past
R1	Abbrev-Of Arg1:E27 Arg2:E5
R2	Abbrev-Of Arg1:E32 Arg2:E1
R3	Caused-By Arg1:E26 Arg2:E20
R4	Example-Of Arg1:E30 Arg2:E9
R5	Example-Of Arg1:E31 Arg2:E9
R6	Caused-By Arg1:E43 Arg2:E41
R7	Example-Of Arg1:E3 Arg2:E41
R8	Example-Of Arg1:E38 Arg2:E41
R9	Example-Of Arg1:E17 Arg2:E41
R10	Example-Of Arg1:E19 Arg2:E41
R11	Example-Of Arg1:E44 Arg2:E41
R12	Example-Of Arg1:E21 Arg2:E41
R13	Example-Of Arg1:E11 Arg2:E56